&bgr;-Amyloid therapies in Alzheimer’s disease

By Jhee S.   Shiovitz T.   Crawford A.W.   Cutler N.R.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 4, 2001-04 ,pp. : 593-605

Informa Healthcare

Access to resources Recommend Favorite

Alzheimer’s disease: towards therapeutic manipulation of the amyloid precursor protein and amyloid &bgr;-peptides

By Larner A.J.   Rossor M.N.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1115-1127

Informa Healthcare

Access to resources Recommend Favorite

The Development of Preventives and Therapeutics for Alzheimer's Disease that Inhibit the Formation of &bgr;-Amyloid Fibrils (fA&bgr;), as Well as Destabilize Preformed fA&bgr;

By  

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4357-4375

Bentham Science Publishers

Access to resources Recommend Favorite

LSD1 inhibition: a therapeutic strategy in cancer?

By Lynch James T   Harris William J   Somervaille Tim C P  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 12, 2012-12 ,pp. : 1239-1249

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Efflux of Quinolines as New Therapeutic Strategy in Malaria

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 7, 2008-04 ,pp. : 563-578

Bentham Science Publishers

Access to resources Recommend Favorite